1-4 of 4
T. M. de Witte, MD, PhD
Close
Sort by
Journal Articles

Impact of Red Blood Cell Transfusion Intensity on Progression-Free Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS Registry

Louise De Swart, MD, Simon Crouch, MSc, PhD, Marlijn Hoeks, MD, Alex Smith, PhD, Saskia Langemeijer, MD PhD, Pierre Fenaux, MD PhD, Argiris Symeonidis, MD PhD, Jaroslav Cermak, MD PhD, Reinhard Stauder, MD, Moshe Mittelman, MD, Guillermo Sanz, MD, Eva Hellstrom-Lindberg, MD PhD, Luca Malcovati, MD, Mette Skov Holm, MD PhD, Ulrich Germing, MD, Krzysztof Madry, MD PhD, Antonio Medina de Almeida, MD PhD, Aurelia Tatic, MD, Aleksandar Savic, Njetočka Gredelj-Šimec, MD, Agnes Guerci Bresler, Dominic Culligan, MD, Raphael Itzykson, MD PhD, Odile Beyne-Rauzy, MD, Sophie Park, MD PhD, Corine van Marrewijk, PhD, Nicole M A Blijlevens, David T. Bowen, MD, T. M. de Witte, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1690.
https://doi.org/10.1182/blood.V130.Suppl_1.1690.1690
Published: 2017
Journal Articles

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Curly Morris, MD, Simona Iacobelli, Gosta Gahrton, MD, Laurent Garderet, MD, Mary Drake, MBBCh, MD, Anja van Biezen, Mohamad Mohty, Didier Blaise, MD, Xavier Poiré, M.D, Marie José Kersten, Noel-Jean Milpied, MD, Stig Lenhoff, MD, PhD, Nigel H. Russell, MD, J.ürgen Finke, T. M. de Witte, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2008.
https://doi.org/10.1182/blood.V118.21.2008.2008
Published: 2011
Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD
Journal: Blood
Blood (2009) 114 (22): 877.
https://doi.org/10.1182/blood.V114.22.877.877
Published: 2009
Journal Articles

Preclinical Ex-Vivo Generation of Clinical Relevant Amounts of NK Cells from CD34+ Progenitor Cells for Immunotherapy

Jan Spanholtz, T. M. de Witte, MD, PhD, Marleen Tordoir, Harry Dolstra
Journal: Blood
Blood (2008) 112 (11): 2916.
https://doi.org/10.1182/blood.V112.11.2916.2916
Published: 2008